Treatment Protocols and Observation
Accessing ketamine therapies involves a comprehensive psychiatric evaluation to determine if these interventions align with your clinical needs. For FDA-approved treatments, Spravato must be administered in a certified healthcare setting. Patients are required to remain on-site for at least two hours of clinical observation following the dose. Because the medication can cause sedation and dissociation, patients cannot drive until the next day, after a restful sleep. Consequently, securing a responsible adult to provide a ride home is a mandatory part of the treatment protocol.
Navigating Travel and Safety
For residents of Canandaigua, traveling to specialty clinics requires careful planning. The Finger Lakes region is subject to intense lake-effect weather and winter snow, which can cause significant delays during the colder months. These conditions, combined with potentially long rural distances to reach certified treatment centers, must be considered when scheduling repeated appointments. While telehealth platforms can support initial assessments and follow-up consultations, Spravato is never administered at home. Furthermore, while some providers prescribe off-label compounded ketamine for home use, these formulations lack FDA approval for psychiatric care, and the FDA has issued warnings regarding the risks of use without on-site monitoring. For immediate mental health support, contact the 988 Suicide & Crisis Lifeline by calling or texting 988, or call 911 for medical emergencies.